These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 2844785)
1. Hydrogen peroxide inhibits alveolar macrophage 5-lipoxygenase metabolism in association with depletion of ATP. Sporn PH; Peters-Golden M J Biol Chem; 1988 Oct; 263(29):14776-83. PubMed ID: 2844785 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of alveolar macrophage 5-lipoxygenase metabolism by auranofin. Peters-Golden M; Shelly C Biochem Pharmacol; 1989 May; 38(10):1589-95. PubMed ID: 2499339 [TBL] [Abstract][Full Text] [Related]
3. Hydrogen peroxide increases the availability of arachidonic acid for oxidative metabolism by inhibiting acylation into phospholipids in the alveolar macrophage. Sporn PH; Marshall TM; Peters-Golden M Am J Respir Cell Mol Biol; 1992 Sep; 7(3):307-16. PubMed ID: 1520493 [TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of exogenous arachidonic acid on alveolar macrophage 5-lipoxygenase metabolism. Role of ATP depletion. Peters-Golden M; Shelly C J Immunol; 1988 Mar; 140(6):1958-66. PubMed ID: 3126237 [TBL] [Abstract][Full Text] [Related]
5. Modulation of alveolar macrophage-derived 5-lipoxygenase products by the sulfhydryl reactant, N-ethylmaleimide. Peters-Golden M; Shelly C J Biol Chem; 1987 Aug; 262(22):10594-600. PubMed ID: 3112148 [TBL] [Abstract][Full Text] [Related]
6. Hydrogen-peroxide-induced arachidonic acid metabolism in the rat alveolar macrophage. Sporn PH; Peters-Golden M; Simon RH Am Rev Respir Dis; 1988 Jan; 137(1):49-56. PubMed ID: 3122612 [TBL] [Abstract][Full Text] [Related]
7. Arachidonic acid metabolism in normal human alveolar macrophages: stimulus specificity for mediator release and phospholipid metabolism, and pharmacologic modulation in vitro and in vivo. Yoss EB; Spannhake EW; Flynn JT; Fish JE; Peters SP Am J Respir Cell Mol Biol; 1990 Jan; 2(1):69-80. PubMed ID: 2155013 [TBL] [Abstract][Full Text] [Related]
8. Comparison of arachidonic acid metabolism by pulmonary intravascular and alveolar macrophages exposed to particulate and soluble stimuli. Bertram TA; Overby LH; Brody AR; Eling TE Lab Invest; 1989 Oct; 61(4):457-66. PubMed ID: 2552225 [TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of leukotriene B4 formation by exogeneous 5-lipoxygenase inhibitors is associated with enhanced generation of 15-hydroxy-eicosatetraenoic acid (15-HETE) by human neutrophils. Fogh K; Herlin T; Kragballe K Arch Dermatol Res; 1988; 280(7):430-6. PubMed ID: 2849922 [TBL] [Abstract][Full Text] [Related]
10. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models. Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987 [TBL] [Abstract][Full Text] [Related]
11. Inhibition by methylprednisolone of zymosan-induced leukotriene synthesis in alveolar macrophages. Peters-Golden M; Thebert P Am Rev Respir Dis; 1987 May; 135(5):1020-6. PubMed ID: 3034108 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of production of LTB4 and chemotactic agent from rat alveolar macrophages treated with t-butyl hydroperoxide is independent of ATP depletion. Robison TW; Duncan DP; Coates TD; Forman HJ Biochim Biophys Acta; 1990 Jun; 1045(1):9-16. PubMed ID: 2164422 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of inhibitors of eicosanoid synthesis in leukocytes: possible pitfall of using the calcium ionophore A23187 to stimulate 5' lipoxygenase. Salmon JA; Tilling LC; Moncada S Prostaglandins; 1985 Mar; 29(3):377-85. PubMed ID: 2988019 [TBL] [Abstract][Full Text] [Related]
14. LTB4 production and lysosomal enzyme release by rat alveolar macrophages: effects of phagocytosis, receptor binding, and ionophore stimulation. Hsueh W; Gonzalez-Crussi F; Henderson S Exp Lung Res; 1987; 13(4):385-99. PubMed ID: 2834192 [TBL] [Abstract][Full Text] [Related]
15. Complex effects of in vitro hyperoxia on alveolar macrophage arachidonic acid metabolism. Sporn PH; Murphy TM; Peters-Golden M Am J Respir Cell Mol Biol; 1990 Jan; 2(1):81-90. PubMed ID: 2155014 [TBL] [Abstract][Full Text] [Related]
16. Metabolism of arachidonic acid through the 5-lipoxygenase pathway in normal human peritoneal macrophages. Laviolette M; Carreau M; Coulombe R; Cloutier D; Dupont P; Rioux J; Braquet P; Borgeat P J Immunol; 1988 Sep; 141(6):2104-9. PubMed ID: 2844895 [TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo. Tateson JE; Randall RW; Reynolds CH; Jackson WP; Bhattacherjee P; Salmon JA; Garland LG Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160 [TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of 5-lipoxygenase pathway in rat pulmonary alveolar macrophages by cigarette smoking. Mobley A; Tanizawa H; Iwanaga T; Tai CL; Tai HH Biochim Biophys Acta; 1987 Apr; 918(2):115-9. PubMed ID: 3030439 [TBL] [Abstract][Full Text] [Related]
19. Calcium ionophore enables soluble agonists to stimulate macrophage 5-lipoxygenase. Tripp CS; Mahoney M; Needleman P J Biol Chem; 1985 May; 260(10):5895-8. PubMed ID: 3922966 [TBL] [Abstract][Full Text] [Related]
20. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products. Tornhamre S; Edenius C; Smedegård G; Sjöquist B; Lindgren JA Eur J Pharmacol; 1989 Oct; 169(2-3):225-34. PubMed ID: 2572437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]